Cheryl London, DVM, PhD
Research Focus - Comparative and Translational Oncology
- Optimizing chemo-immunotherapy approaches
- Targeting the tumor microenvironment in metastatic sarcoma
- Comparative cancer genomics using dogs as a spontaneous tumor model
- Validating novel targets for therapeutic intervention in spontaneous canine cancer
Representative Publication
London CA, Acquaviva J, Smith DL, et al. Consecutive day HSP90 inhibitor administration improves efficacy in murine models of KIT-driven malignancies and canine mast cell tumors. Clin Cancer Res. 2018;24(24):6396-6407.